The Equity Club, advised by New Deal Advisors, acquired a minority stake in Lincotek, an Italian high-performance coatings company, to support its international growth and merger strategy.
Target Company Overview
New Deal Advisors has facilitated The Equity Club (TEC), a club deal sponsored by Mediobanca's private banking division, in acquiring a minority stake in Lincotek. Founded in 1973 as Turbocoating, Lincotek is an Italian company that specializes in high-performance biocompatible metal coatings for orthopedic implants and thermoresistant coatings to enhance the durability and performance of gas turbines used in the aviation sector. The Antolotti family will retain control of the company, maintaining over 75% of ownership.
Today, Lincotek operates 16 facilities across Europe, North America (with six dedicated to the medical sector and two to aviation), and China. The proceeds from this deal will aid in supporting Lincotek's merger and acquisition strategy, thereby strengthening its international presence. The goal is to expand its range of technologies and services and to become a fully integrated player in its sectors on a global scale.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The medical device and aviation coatings industry in Italy has been witnessing significant advancements, driven by innovations in technology and growing demand for quality and performance. With an increase in the aging population, there is a rising need for orthopedic implan
Similar Deals
Engineering → OPOH - One Person One Health
2025
Lupin Ltd. → Bausch VISUfarma Pharma’s ophthalmology portfolio
2025
Lifenet Healthcare → Cab Polidiagnostico
2023
Funecap Funeral Service → Centro Funerario Bergamasco
2023
The Equity Club
invested in
Lincotek
in 2021
in a Other deal